http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2110800-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f378e04d947047b0e85d89e859633b31
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 1996-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa147eb2cd9b4e3e05d400a2aaf8e362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ba485cd89ec21a02660afe62bc3dbd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_087d531fc71e81e651a10eb764ad0522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd65e9366c609019befec6ee006a36c
publicationDate 1998-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2110800-C1
titleOfInvention Method for earlier diagnostics of intrauterine infection
abstract FIELD: medicine, obstetrics, gynecology, diagnostics. SUBSTANCE: blood sampling is conducted in women at the second trimester of their pregnancy to determine the presence of C-reactive protein by using immunological method of capillary precipitation and that of placental alpha-1-microglobulin by applying "Placental alpha-1-microglobulin-Fertitest" which is based upon the usage of monoclonal antibodies. To conduct bacteriological and cytological trials it is necessary to observe smears taken from cervical canal of uterine cervix and posterior vaginal fornix for further detection of inflammatory reaction signs caused by different specific and non-specific microflora. At the level of placental alpha-1-microglobulin > or = 30 ng/ml, at the absence of C-reactive protein and noninfected genital organs a placental deficiency of non-infectious genesis is predicted, and at the level of placental alpha-1-microglobulin > or = 30 ng/ml, at the presence of C-reactive protein and infected genital organs an intrauterine infection (placental deficiency of infectious genesis) is predicted. EFFECT: higher specificity and accuracy of diagnostics.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11353464-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2204654-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105008925-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10422802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9429580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9891233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10656164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9494596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9568479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771877-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10935555-B2
priorityDate 1996-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1401
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID751795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19094
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444374
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14847
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02742
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02741
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07203
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO19062
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49262
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12944
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49254

Total number of triples: 44.